DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Orap (Pimozide) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Orap (Pimozide) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (9)

Reports by Reaction Type

Fear (3)Suicidal Ideation (3)Anxiety (3)Depression (3)Vomiting (2)Rhabdomyolysis (2)Hyponatraemia (2)Diarrhoea (2)Inappropriate Antidiuretic Hormone Secretion (2)Refusal of Treatment by Patient (1)Ventricular Extrasystoles (1)Abdominal Pain (1)

Possible Orap side effects in female

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-14

Patient: female

Reactions: Ventricular Extrasystoles, Dystonia, Multiple Drug Overdose

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Escitalopram
    Dosage: one intake of 10 tab. of 10 mg
    Administration route: Oral
    Start date: 2012-04-30
    End date: 2012-04-30

Orap
    Dosage: one intake of 10 tab. of 1 mg
    Administration route: Oral
    Start date: 2012-04-30
    End date: 2012-04-30

Paroxetine
    Dosage: one intake of 2 tab. of 20 mg
    Administration route: Oral
    Start date: 2012-04-30
    End date: 2012-04-30



Possible Orap side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-23

Patient: female, weighing 98.5 kg (216.7 pounds)

Reactions: Anxiety, Fear, Depression, Suicidal Ideation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Orap
    Dosage: 4 milligram;
    Administration route: Oral
    Indication: Tourette's Disorder
    Start date: 1985-01-01
    End date: 2012-03-01

Orap
    Dosage: 2 milligram;
    Administration route: Oral
    Start date: 1985-01-01
    End date: 1995-01-01



Possible Orap side effects in 16 year old female

Reported by a physician from Denmark on 2012-04-23

Patient: 16 year old female, weighing 64.0 kg (140.8 pounds)

Reactions: Blood Creatine Phosphokinase Increased, Aspartate Aminotransferase Increased, Acute Psychosis, Neuroleptic Malignant Syndrome, Stupor, Leukocytosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ziprasidone Hydrochloride
    Dosage: 80 mg
    End date: 2012-03-23

Zyprexa
    Dosage: 10 mg, as needed
    Administration route: Oral
    Indication: Psychotic Disorder
    Start date: 2012-02-24
    End date: 2012-03-23

Ziprasidone Hydrochloride
    Dosage: 40 mg, 2x/day
    Administration route: Oral
    Indication: Psychotic Disorder
    Start date: 2010-01-01
    End date: 2012-03-23

Ziprasidone Hydrochloride
    Dosage: 60 mg

Orap
    Dosage: dose 2 mg, strength 1 mg
    Administration route: Oral
    Indication: Tourette's Disorder
    Start date: 2007-01-01
    End date: 2012-03-23

Other drugs received by patient: Clonidine; Topamax



Possible Orap side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-13

Patient: female, weighing 98.5 kg (216.7 pounds)

Reactions: Anxiety, Depression, Suicidal Ideation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Orap
    Dosage: 4 milligram;
    Administration route: Oral
    Indication: Tourette's Disorder
    Start date: 1985-01-01
    End date: 2012-03-01

Orap
    Dosage: 2 milligram;
    Administration route: Oral
    Start date: 1985-01-01
    End date: 1995-01-01



Possible Orap side effects in 59 year old female

Reported by a consumer/non-health professional from United States on 2012-04-10

Patient: 59 year old female, weighing 98.4 kg (216.5 pounds)

Reactions: Anxiety, Refusal of Treatment by Patient, Fear, Condition Aggravated, Tourette's Disorder

Drug(s) suspected as cause:
Haldol
    Dosage: 5 mg;qd;po
    Administration route: Oral
    Indication: Tourette's Disorder
    Start date: 2012-03-28

Pimozide (NO Pref. Name)
    Dosage: 4 mg;qd;po
    Administration route: Oral
    End date: 2012-03-01

Orap
    Dosage: 2 mg;qd;po
    Administration route: Oral
    Indication: Tourette's Disorder
    Start date: 1985-01-01

Orap
    Dosage: 2 mg;qd;po
    Administration route: Oral
    Indication: Condition Aggravated
    Start date: 1985-01-01

Benztropine Mesylate
    Dosage: ;qd or bid;
    Indication: Adverse Event
    Start date: 2012-01-01
    End date: 2012-01-01



Possible Orap side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-09

Patient: female, weighing 98.5 kg (216.7 pounds)

Reactions: Depression, Suicidal Ideation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Orap
    Dosage: 2 milligram;
    Administration route: Oral
    Start date: 1985-01-01
    End date: 1995-01-01

Orap
    Dosage: 4 milligram;
    Administration route: Oral
    Indication: Tourette's Disorder
    Start date: 1985-01-01
    End date: 2012-03-01



Possible Orap side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-30

Patient: female

Reactions: Abdominal Pain, Therapeutic Response Unexpected, Fear, Dyskinesia

Drug(s) suspected as cause:
Orap
    Administration route: Oral
    Indication: Tourette's Disorder

Benztropine Mesylate



Possible Orap side effects in 45 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2011-10-13

Patient: 45 year old female

Reactions: Vomiting, Rhabdomyolysis, Diarrhoea, Inappropriate Antidiuretic Hormone Secretion, Hyponatraemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Orap
    Dosage: unk
    Administration route: Oral

Zoloft
    Dosage: unk
    Administration route: Oral

Other drugs received by patient: Trihexyphenidyl Hydrochloride; Milligynon



Possible Orap side effects in 45 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2011-10-05

Patient: 45 year old female

Reactions: Rhabdomyolysis, Vomiting, Diarrhoea, Inappropriate Antidiuretic Hormone Secretion, Hyponatraemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zoloft
    Administration route: Oral

Orap
    Administration route: Oral

Other drugs received by patient: Milligynon; Trihexyphenidyl Hydrochloride

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014